SARS coronavirus and innate immunity

Abstract The emergence of the highly pathogenic SARS coronavirus (SARS-CoV) has reignited interest in coronavirus biology and pathogenesis. An emerging theme in coronavirus pathogenesis is that the interaction between specific viral genes and the host immune system, specifically the innate immune system, functions as a key determinant in regulating virulence and disease outcomes. Using SARS-CoV as a model, we will review the current knowledge of the interplay between coronavirus infection and the host innate immune system in vivo, and then discuss the mechanisms by which specific gene products antagonize the host innate immune response in cell culture models. Our data suggests that the SARS-CoV uses specific strategies to evade and antagonize the sensing and signaling arms of the interferon pathway. We summarize by identifying future points of consideration that will contribute greatly to our understanding of the molecular mechanisms governing coronavirus pathogenesis and virulence, and the development of severe disease in humans and animals.

[1]  Jing Li,et al.  Analysis of Serum Cytokines in Patients with Severe Acute Respiratory Syndrome , 2004, Infection and Immunity.

[2]  B. Williams,et al.  Blockade of Interferon Induction and Action by the E3L Double-Stranded RNA Binding Proteins of Vaccinia Virus , 2002, Journal of Virology.

[3]  G. Sen,et al.  Viruses and interferons. , 2001, Annual review of microbiology.

[4]  Renji Reghunathan,et al.  Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome , 2005, BMC Immunology.

[5]  S. Perlman,et al.  Mouse Hepatitis Virus Does Not Induce Beta Interferon Synthesis and Does Not Inhibit Its Induction by Double-Stranded RNA , 2006, Journal of Virology.

[6]  W. Spaan,et al.  Group 2 coronaviruses prevent immediate early interferon induction by protection of viral RNA from host cell recognition , 2007, Virology.

[7]  M. Katze,et al.  Global Suppression of the Host Antiviral Response by Ebola- and Marburgviruses: Increased Antagonism of the Type I Interferon Response Is Associated with Enhanced Virulence , 2006, Journal of Virology.

[8]  M. Diamond,et al.  Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus. , 2003, Viral immunology.

[9]  J. Peiris,et al.  Academic Editor: Sherif Zaki, Centers for Disease Control, United States of America , 2005 .

[10]  S. Akira,et al.  Recognition of pathogen-associated molecular patterns by TLR family. , 2003, Immunology letters.

[11]  J. Hiscott,et al.  Recruitment of an interferon molecular signaling complex to the mitochondrial membrane: disruption by hepatitis C virus NS3-4A protease. , 2006, Biochemical pharmacology.

[12]  A. Pichlmair,et al.  RIG-I-Mediated Antiviral Responses to Single-Stranded RNA Bearing 5'-Phosphates , 2006, Science.

[13]  Persephone Borrow,et al.  Viral infection switches non-plasmacytoid dendritic cells into high interferon producers , 2003, Nature.

[14]  S. Schleich,et al.  Localization of Mouse Hepatitis Virus Nonstructural Proteins and RNA Synthesis Indicates a Role for Late Endosomes in Viral Replication , 1999, Journal of Virology.

[15]  S. Diamond,et al.  Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[16]  S. Weiss,et al.  Coronavirus Pathogenesis and the Emerging Pathogen Severe Acute Respiratory Syndrome Coronavirus , 2005, Microbiology and Molecular Biology Reviews.

[17]  C. Agrati,et al.  Coordinate induction of IFN-α and -γ by SARS-CoV also in the absence of virus replication , 2005, Virology.

[18]  R. Baric,et al.  Coronavirus Genome Structure and Replication , 2005, Current topics in microbiology and immunology.

[19]  N. Kadowaki,et al.  The nature of the principal type 1 interferon-producing cells in human blood. , 1999, Science.

[20]  T. Ouchi,et al.  Measles Virus V Protein Inhibits p53 Family Member p73 , 2006, Journal of Virology.

[21]  Andreas Pichlmair,et al.  Inhibition of Beta Interferon Induction by Severe Acute Respiratory Syndrome Coronavirus Suggests a Two-Step Model for Activation of Interferon Regulatory Factor 3 , 2005, Journal of Virology.

[22]  P. Österlund,et al.  Severe Acute Respiratory Syndrome Coronavirus Fails To Activate Cytokine-Mediated Innate Immune Responses in Cultured Human Monocyte-Derived Dendritic Cells , 2005, Journal of Virology.

[23]  F. Weber,et al.  Interaction of severe acute respiratory syndrome-associated coronavirus with dendritic cells. , 2006, The Journal of general virology.

[24]  C. Hsiao,et al.  Modeling the Early Events of Severe Acute Respiratory Syndrome Coronavirus Infection In Vitro , 2006, Journal of Virology.

[25]  S. Nichol,et al.  A C-terminal basic amino acid motif of Zaire ebolavirus VP35 is essential for type I interferon antagonism and displays high identity with the RNA-binding domain of another interferon antagonist, the NS1 protein of influenza A virus. , 2004, Virology.

[26]  H. Doerr,et al.  Infection of cultured intestinal epithelial cells with severe acute respiratory syndrome coronavirus , 2004, Cellular and Molecular Life Sciences CMLS.

[27]  Andrew Pekosz,et al.  The ORF7b Protein of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Is Expressed in Virus-Infected Cells and Incorporated into SARS-CoV Particles , 2006, Journal of Virology.

[28]  A. Alcamí,et al.  Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species soecificity , 1995, Cell.

[29]  T. Graf,et al.  Determinants of lymphoid-myeloid lineage diversification. , 2006, Annual review of immunology.

[30]  Christine A. Biron,et al.  Type 1 Interferons and the Virus-Host Relationship: A Lesson in Détente , 2006, Science.

[31]  C. Peters,et al.  Severe Acute Respiratory Syndrome Coronavirus Accessory Protein 6 Is a Virion-Associated Protein and Is Released from 6 Protein-Expressing Cells , 2007, Journal of Virology.

[32]  H. Laude,et al.  Induction of alpha interferon by transmissible gastroenteritis coronavirus: role of transmembrane glycoprotein E1 , 1988, Journal of virology.

[33]  Tzei-Yi Lin,et al.  Detection of Severe Acute Respiratory Syndrome–Associated Coronavirus in Pneumocytes of the Lung , 2004, American journal of clinical pathology.

[34]  Erica Ollmann Saphire,et al.  Ebola Virus VP35 Protein Binds Double-Stranded RNA and Inhibits Alpha/Beta Interferon Production Induced by RIG-I Signaling , 2006, Journal of Virology.

[35]  Christian Drosten,et al.  Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome , 2003, Science.

[36]  S. Makino,et al.  Severe Acute Respiratory Syndrome Coronavirus 7a Accessory Protein Is a Viral Structural Protein , 2006, Journal of Virology.

[37]  A. Takaoka,et al.  Interferon signalling network in innate defence , 2006, Cellular microbiology.

[38]  V. Volchkov,et al.  The Ebola virus VP35 protein functions as a type I IFN antagonist. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[39]  E. Saphire,et al.  Ebola Virus VP 35 Protein Binds Double-Stranded RNA and Inhibits Alpha / Beta Interferon Production Induced by RIGI Signaling , 2006 .

[40]  Obi L. Griffith,et al.  The Genome Sequence of the SARS-Associated Coronavirus , 2003, Science.

[41]  Deborah Chavez,et al.  Antiviral Effect and Virus-Host Interactions in Response to Alpha Interferon, Gamma Interferon, Poly(I)-Poly(C), Tumor Necrosis Factor Alpha, and Ribavirin in Hepatitis C Virus Subgenomic Replicons , 2003, Journal of Virology.

[42]  B. Hogue,et al.  Mouse Hepatitis Coronavirus A59 Nucleocapsid Protein Is a Type I Interferon Antagonist , 2006, Journal of Virology.

[43]  R. Baric,et al.  Single-Amino-Acid Substitutions in Open Reading Frame (ORF) 1b-nsp14 and ORF 2a Proteins of the Coronavirus Mouse Hepatitis Virus Are Attenuating in Mice , 2005, Journal of Virology.

[44]  H. Tsutsumi,et al.  Cytokine regulation in SARS coronavirus infection compared to other respiratory virus infections† , 2006, Journal of medical virology.

[45]  J. A. Comer,et al.  Ultrastructural Characterization of SARS Coronavirus , 2004, Emerging infectious diseases.

[46]  J. Onderwater,et al.  Ultrastructure and Origin of Membrane Vesicles Associated with the Severe Acute Respiratory Syndrome Coronavirus Replication Complex , 2006, Journal of Virology.

[47]  Qiang Sun,et al.  Dissociation of a MAVS/IPS-1/VISA/Cardif-IKKε Molecular Complex from the Mitochondrial Outer Membrane by Hepatitis C Virus NS3-4A Proteolytic Cleavage , 2006, Journal of Virology.

[48]  T. Hovi,et al.  Induction of interferon in human leukocyte cultures by natural pathogenic respiratory viruses. , 1993, Journal of interferon research.

[49]  G. Stark,et al.  How cells respond to interferons. , 1998, Annual review of biochemistry.

[50]  Xiaotao Lu,et al.  Effects of Mutagenesis of Murine Hepatitis Virus NSP1 and NSP14 on Replication in Culture , 2006, Advances in experimental medicine and biology.

[51]  R. Lamb,et al.  The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2. , 2001, Virology.

[52]  J. Hiscott,et al.  MasterCARD: a priceless link to innate immunity. , 2006, Trends in molecular medicine.

[53]  M. Gunn,et al.  Cd11c+B220+Gr-1+ Cells in Mouse Lymph Nodes and Spleen Display Characteristics of Plasmacytoid Dendritic Cells , 2001, The Journal of experimental medicine.

[54]  P. Palese,et al.  Severe Acute Respiratory Syndrome Coronavirus Open Reading Frame (ORF) 3b, ORF 6, and Nucleocapsid Proteins Function as Interferon Antagonists , 2006, Journal of Virology.

[55]  Nicole M. Bouvier,et al.  Newcastle Disease Virus (NDV)-Based Assay Demonstrates Interferon-Antagonist Activity for the NDV V Protein and the Nipah Virus V, W, and C Proteins , 2003, Journal of Virology.

[56]  S. Goodbourn,et al.  The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[57]  Kwok-Hung Chan,et al.  Comparative Host Gene Transcription by Microarray Analysis Early after Infection of the Huh7 Cell Line by Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus 229E , 2005, Journal of Virology.

[58]  M. Yilla,et al.  SARS-coronavirus replication in human peripheral monocytes/macrophages , 2004, Virus Research.

[59]  D. Jarrossay,et al.  Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon , 1999, Nature Medicine.

[60]  F. Taguchi,et al.  Difference in sensitivity to interferon among mouse hepatitis viruses with high and low virulence for mice , 1985, Virology.

[61]  K. Bienz,et al.  RNA Replication of Mouse Hepatitis Virus Takes Place at Double-Membrane Vesicles , 2002, Journal of Virology.

[62]  Zhengfan Jiang,et al.  Antagonism between MyD88‐ and TRIF‐dependent signals in B7RP‐1 up‐regulation , 2005, European journal of immunology.

[63]  Zhijian J. Chen,et al.  Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[64]  Lucy A. Perrone,et al.  Severe Acute Respiratory Syndrome and the Innate Immune Responses: Modulation of Effector Cell Function without Productive Infection1 , 2005, The Journal of Immunology.

[65]  Michael G. Katze,et al.  Viruses and interferon: a fight for supremacy , 2002, Nature Reviews Immunology.

[66]  G. Tse,et al.  Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in‐situ hybridization study of fatal cases , 2004, The Journal of pathology.

[67]  Tomoki Ito,et al.  Plasmacytoid dendritic cell precursors/type I interferon-producing cells sense viral infection by Toll-like receptor (TLR) 7 and TLR9 , 2004, Springer Seminars in Immunopathology.

[68]  M. Katze,et al.  Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. , 1997, Virology.

[69]  C. Horvath,et al.  Nipah Virus V Protein Evades Alpha and Gamma Interferons by Preventing STAT1 and STAT2 Activation and Nuclear Accumulation , 2002, Journal of Virology.

[70]  Zheng-hong Yuan,et al.  Gene expression profiles in peripheral blood mononuclear cells of SARS patients. , 2005, World journal of gastroenterology.

[71]  Stanley M Lemon,et al.  Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[72]  S. Akira,et al.  Control of coronavirus infection through plasmacytoid dendritic-cell–derived type I interferon , 2007, Blood.

[73]  G. Trinchieri,et al.  Plasmacytoid dendritic cells in immunity , 2004, Nature Immunology.

[74]  Ralf Bartenschlager,et al.  Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus , 2005, Nature.

[75]  Y. Lau,et al.  Chemokine up-regulation in SARS-coronavirus–infected, monocyte-derived human dendritic cells , 2005, Blood.

[76]  J. Lindenmann,et al.  Virus interference. I. The interferon , 1957, Proceedings of the Royal Society of London. Series B - Biological Sciences.

[77]  W. Hong,et al.  The severe acute respiratory syndrome coronavirus 3a is a novel structural protein , 2005, Biochemical and Biophysical Research Communications.

[78]  M. Denison,et al.  Characterization of the Expression, Intracellular Localization, and Replication Complex Association of the Putative Mouse Hepatitis Virus RNA-Dependent RNA Polymerase , 2003, Journal of Virology.

[79]  Gunther Hartmann,et al.  5'-Triphosphate RNA Is the Ligand for RIG-I , 2006, Science.

[80]  Jun Xu,et al.  Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome. , 2005, American journal of respiratory and critical care medicine.